Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Milk, Human | 59 | 2025 | 201 | 13.480 |
Why?
|
Breast Feeding | 56 | 2025 | 170 | 11.630 |
Why?
|
Infant, Very Low Birth Weight | 50 | 2022 | 188 | 10.290 |
Why?
|
Intensive Care Units, Neonatal | 59 | 2025 | 210 | 9.200 |
Why?
|
Infant, Premature | 60 | 2025 | 218 | 8.510 |
Why?
|
Mothers | 40 | 2025 | 186 | 7.950 |
Why?
|
Infant, Newborn | 109 | 2025 | 642 | 6.070 |
Why?
|
Lactation | 23 | 2023 | 62 | 5.060 |
Why?
|
Breast Milk Expression | 13 | 2020 | 42 | 4.850 |
Why?
|
Intensive Care, Neonatal | 11 | 2020 | 37 | 3.100 |
Why?
|
Infant Nutritional Physiological Phenomena | 28 | 2025 | 80 | 3.090 |
Why?
|
Infant | 30 | 2025 | 564 | 2.160 |
Why?
|
Enterocolitis, Necrotizing | 11 | 2020 | 49 | 2.060 |
Why?
|
Female | 80 | 2025 | 15212 | 1.840 |
Why?
|
Mother-Child Relations | 7 | 2017 | 28 | 1.760 |
Why?
|
Humans | 112 | 2025 | 27072 | 1.690 |
Why?
|
Child Development | 10 | 2020 | 73 | 1.560 |
Why?
|
Infant, Premature, Diseases | 7 | 2020 | 30 | 1.490 |
Why?
|
Neonatal Nursing | 12 | 2018 | 19 | 1.460 |
Why?
|
Gestational Age | 16 | 2020 | 89 | 1.330 |
Why?
|
Peer Group | 6 | 2017 | 35 | 1.330 |
Why?
|
Social Support | 6 | 2019 | 196 | 1.200 |
Why?
|
Maternal Behavior | 4 | 2017 | 11 | 1.200 |
Why?
|
Bronchopulmonary Dysplasia | 3 | 2019 | 18 | 1.120 |
Why?
|
Adult | 38 | 2025 | 7831 | 1.050 |
Why?
|
Milk Banks | 6 | 2020 | 22 | 1.000 |
Why?
|
Bottle Feeding | 8 | 2016 | 16 | 0.990 |
Why?
|
Health Care Costs | 5 | 2020 | 75 | 0.990 |
Why?
|
Patient Discharge | 9 | 2025 | 158 | 0.990 |
Why?
|
Prospective Studies | 19 | 2019 | 1778 | 0.960 |
Why?
|
Counseling | 5 | 2013 | 42 | 0.890 |
Why?
|
Postpartum Period | 3 | 2021 | 24 | 0.870 |
Why?
|
Goals | 4 | 2017 | 43 | 0.850 |
Why?
|
Infant, Low Birth Weight | 7 | 2019 | 18 | 0.820 |
Why?
|
Male | 38 | 2025 | 14772 | 0.800 |
Why?
|
Infant, Newborn, Diseases | 4 | 2020 | 15 | 0.790 |
Why?
|
Precision Medicine | 1 | 2022 | 26 | 0.790 |
Why?
|
Socioeconomic Factors | 4 | 2020 | 302 | 0.740 |
Why?
|
Postnatal Care | 2 | 2013 | 7 | 0.720 |
Why?
|
Healthcare Disparities | 2 | 2020 | 88 | 0.690 |
Why?
|
Educational Status | 5 | 2019 | 293 | 0.690 |
Why?
|
Social Determinants of Health | 1 | 2020 | 32 | 0.680 |
Why?
|
Nutritive Value | 5 | 2020 | 25 | 0.670 |
Why?
|
Health Promotion | 4 | 2013 | 143 | 0.660 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 25 | 0.650 |
Why?
|
Enteral Nutrition | 4 | 2018 | 66 | 0.650 |
Why?
|
Contraception Behavior | 1 | 2019 | 5 | 0.640 |
Why?
|
Sepsis | 3 | 2019 | 113 | 0.610 |
Why?
|
Anthropometry | 6 | 2007 | 34 | 0.600 |
Why?
|
Hospitalization | 6 | 2019 | 300 | 0.570 |
Why?
|
Birth Weight | 7 | 2020 | 46 | 0.570 |
Why?
|
Stress, Psychological | 2 | 2019 | 235 | 0.540 |
Why?
|
Child Language | 2 | 2017 | 19 | 0.540 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2019 | 231 | 0.540 |
Why?
|
Chicago | 7 | 2017 | 949 | 0.540 |
Why?
|
Resilience, Psychological | 1 | 2017 | 26 | 0.530 |
Why?
|
Infant Care | 6 | 2016 | 19 | 0.520 |
Why?
|
Depression, Postpartum | 2 | 2017 | 14 | 0.520 |
Why?
|
Puerperal Disorders | 1 | 2015 | 5 | 0.490 |
Why?
|
Infant Formula | 6 | 2020 | 22 | 0.480 |
Why?
|
Cost Savings | 1 | 2015 | 32 | 0.470 |
Why?
|
Longitudinal Studies | 8 | 2019 | 1368 | 0.470 |
Why?
|
Young Adult | 7 | 2019 | 1994 | 0.470 |
Why?
|
Retrospective Studies | 12 | 2025 | 3538 | 0.470 |
Why?
|
Weight Gain | 5 | 2018 | 64 | 0.460 |
Why?
|
Suction | 3 | 2010 | 40 | 0.450 |
Why?
|
Energy Intake | 4 | 2018 | 83 | 0.450 |
Why?
|
Research Support as Topic | 2 | 2005 | 14 | 0.450 |
Why?
|
Motor Activity | 2 | 2017 | 323 | 0.450 |
Why?
|
Infant, Extremely Low Birth Weight | 3 | 2012 | 23 | 0.450 |
Why?
|
Retinopathy of Prematurity | 1 | 2014 | 7 | 0.450 |
Why?
|
Patient Education as Topic | 5 | 2013 | 131 | 0.440 |
Why?
|
Intestines | 2 | 2013 | 80 | 0.440 |
Why?
|
Anxiety Disorders | 1 | 2015 | 171 | 0.440 |
Why?
|
Hospital Costs | 1 | 2013 | 59 | 0.400 |
Why?
|
Direct Service Costs | 1 | 2012 | 4 | 0.400 |
Why?
|
Attitude to Health | 1 | 2013 | 99 | 0.390 |
Why?
|
Premature Birth | 2 | 2023 | 11 | 0.380 |
Why?
|
Perception | 2 | 2020 | 77 | 0.380 |
Why?
|
Breast | 2 | 2008 | 28 | 0.370 |
Why?
|
Nurse's Role | 5 | 2007 | 59 | 0.370 |
Why?
|
Risk Factors | 7 | 2016 | 2302 | 0.360 |
Why?
|
Reproducibility of Results | 10 | 2006 | 676 | 0.350 |
Why?
|
United States | 10 | 2020 | 2035 | 0.340 |
Why?
|
Incidence | 6 | 2020 | 759 | 0.340 |
Why?
|
Nurseries, Hospital | 2 | 2007 | 3 | 0.320 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 261 | 0.320 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2017 | 164 | 0.310 |
Why?
|
Clinical Nursing Research | 2 | 2002 | 4 | 0.310 |
Why?
|
Child, Preschool | 3 | 2020 | 641 | 0.310 |
Why?
|
Cognition | 2 | 2017 | 1339 | 0.300 |
Why?
|
Diet | 3 | 2018 | 220 | 0.300 |
Why?
|
Qualitative Research | 4 | 2017 | 114 | 0.300 |
Why?
|
Lipids | 2 | 2006 | 51 | 0.300 |
Why?
|
Animals | 7 | 2020 | 3642 | 0.290 |
Why?
|
Body Weight | 6 | 1996 | 134 | 0.290 |
Why?
|
Child | 4 | 2021 | 1295 | 0.290 |
Why?
|
Biomarkers | 3 | 2020 | 562 | 0.290 |
Why?
|
Anxiety | 2 | 2019 | 156 | 0.280 |
Why?
|
Maternal Age | 3 | 2019 | 15 | 0.260 |
Why?
|
Interviews as Topic | 3 | 2017 | 132 | 0.260 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 32 | 0.260 |
Why?
|
Residence Characteristics | 2 | 2019 | 214 | 0.260 |
Why?
|
Maternal-Child Nursing | 2 | 2004 | 4 | 0.260 |
Why?
|
Centrifugation | 1 | 2006 | 4 | 0.250 |
Why?
|
Colostrum | 3 | 2010 | 5 | 0.250 |
Why?
|
Decision Making | 4 | 2015 | 223 | 0.240 |
Why?
|
Milk Ejection | 3 | 2011 | 3 | 0.240 |
Why?
|
Research | 1 | 2005 | 39 | 0.240 |
Why?
|
Child Nutrition Sciences | 1 | 2005 | 3 | 0.240 |
Why?
|
Adolescent | 7 | 2017 | 2172 | 0.230 |
Why?
|
Evidence-Based Practice | 2 | 2016 | 72 | 0.230 |
Why?
|
Parent-Child Relations | 1 | 2004 | 37 | 0.230 |
Why?
|
Cohort Studies | 6 | 2020 | 1890 | 0.220 |
Why?
|
Toxoplasmosis, Congenital | 3 | 2011 | 8 | 0.220 |
Why?
|
Mass Media | 1 | 2004 | 10 | 0.220 |
Why?
|
Nursing Evaluation Research | 4 | 2015 | 19 | 0.210 |
Why?
|
Pregnancy | 7 | 2019 | 336 | 0.210 |
Why?
|
Financing, Government | 1 | 2003 | 9 | 0.210 |
Why?
|
Parents | 1 | 2004 | 113 | 0.210 |
Why?
|
Nutritional Status | 2 | 2020 | 58 | 0.210 |
Why?
|
Health Policy | 1 | 2003 | 42 | 0.200 |
Why?
|
Aftercare | 3 | 2018 | 24 | 0.200 |
Why?
|
Cost of Illness | 2 | 2013 | 50 | 0.200 |
Why?
|
Nutritional Support | 3 | 2018 | 24 | 0.190 |
Why?
|
Attitude of Health Personnel | 2 | 2013 | 145 | 0.180 |
Why?
|
Oxidative Stress | 2 | 2018 | 94 | 0.180 |
Why?
|
Age Factors | 2 | 2020 | 766 | 0.180 |
Why?
|
Health Expenditures | 1 | 2020 | 17 | 0.180 |
Why?
|
Neonatology | 1 | 2020 | 4 | 0.170 |
Why?
|
Protective Devices | 1 | 2000 | 2 | 0.170 |
Why?
|
Nipples | 1 | 2000 | 5 | 0.170 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 123 | 0.170 |
Why?
|
Tissue Donors | 2 | 2021 | 79 | 0.170 |
Why?
|
Linear Models | 3 | 2017 | 247 | 0.160 |
Why?
|
Child of Impaired Parents | 1 | 2019 | 10 | 0.160 |
Why?
|
Intestinal Mucosa | 2 | 2018 | 156 | 0.160 |
Why?
|
Time Factors | 6 | 2018 | 1433 | 0.160 |
Why?
|
Directive Counseling | 1 | 2019 | 12 | 0.160 |
Why?
|
Intention | 1 | 2019 | 21 | 0.160 |
Why?
|
Acute Disease | 1 | 2019 | 176 | 0.160 |
Why?
|
Pregnancy Complications | 1 | 2019 | 45 | 0.160 |
Why?
|
Body Mass Index | 1 | 2021 | 458 | 0.160 |
Why?
|
Program Evaluation | 2 | 2013 | 120 | 0.160 |
Why?
|
Inflammation | 2 | 2018 | 272 | 0.160 |
Why?
|
Obesity | 1 | 2021 | 311 | 0.150 |
Why?
|
Return to Work | 2 | 2016 | 65 | 0.150 |
Why?
|
Feeding Methods | 2 | 2013 | 5 | 0.150 |
Why?
|
Pilot Projects | 2 | 2018 | 420 | 0.150 |
Why?
|
Social Class | 1 | 2019 | 67 | 0.150 |
Why?
|
Biomedical Research | 2 | 2016 | 56 | 0.150 |
Why?
|
Depression | 2 | 2019 | 444 | 0.150 |
Why?
|
Multivariate Analysis | 2 | 2017 | 329 | 0.150 |
Why?
|
Cell Death | 1 | 2018 | 45 | 0.150 |
Why?
|
Follow-Up Studies | 2 | 2020 | 1792 | 0.150 |
Why?
|
Sucking Behavior | 2 | 1994 | 2 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 77 | 0.140 |
Why?
|
Neurodevelopmental Disorders | 1 | 2017 | 18 | 0.140 |
Why?
|
Nervous System | 1 | 2017 | 11 | 0.140 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 370 | 0.140 |
Why?
|
Pregnancy in Adolescence | 1 | 2017 | 11 | 0.140 |
Why?
|
Eating | 2 | 2011 | 58 | 0.140 |
Why?
|
Narration | 1 | 2017 | 12 | 0.140 |
Why?
|
Tertiary Care Centers | 1 | 2017 | 68 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2016 | 37 | 0.130 |
Why?
|
Program Development | 2 | 2014 | 51 | 0.130 |
Why?
|
Science | 1 | 1996 | 4 | 0.130 |
Why?
|
Nurse-Patient Relations | 2 | 2015 | 44 | 0.130 |
Why?
|
Severity of Illness Index | 1 | 2019 | 879 | 0.130 |
Why?
|
Weaning | 1 | 2016 | 5 | 0.130 |
Why?
|
Nutrition Assessment | 1 | 1996 | 42 | 0.130 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 175 | 0.130 |
Why?
|
Illinois | 1 | 2016 | 250 | 0.130 |
Why?
|
Informed Consent | 1 | 2015 | 23 | 0.120 |
Why?
|
Guidelines as Topic | 1 | 2016 | 57 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 47 | 0.120 |
Why?
|
Nigeria | 2 | 2007 | 4 | 0.120 |
Why?
|
Bacteria | 1 | 2016 | 70 | 0.120 |
Why?
|
Chondroitinases and Chondroitin Lyases | 1 | 2015 | 4 | 0.120 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2015 | 14 | 0.120 |
Why?
|
Incubators, Infant | 2 | 1995 | 2 | 0.120 |
Why?
|
Life Change Events | 1 | 2015 | 37 | 0.120 |
Why?
|
Length of Stay | 1 | 2017 | 313 | 0.120 |
Why?
|
Ambulatory Care | 1 | 2015 | 69 | 0.110 |
Why?
|
Beds | 1 | 1994 | 3 | 0.110 |
Why?
|
Home Nursing | 1 | 1994 | 33 | 0.110 |
Why?
|
Nursing Staff, Hospital | 2 | 1993 | 25 | 0.110 |
Why?
|
Morbidity | 1 | 2014 | 54 | 0.110 |
Why?
|
Focus Groups | 1 | 1994 | 87 | 0.110 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 482 | 0.110 |
Why?
|
Milk | 2 | 2012 | 14 | 0.110 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 30 | 0.110 |
Why?
|
Patient Readmission | 1 | 2015 | 129 | 0.110 |
Why?
|
Gastrointestinal Microbiome | 1 | 2016 | 158 | 0.110 |
Why?
|
Swine | 1 | 2013 | 79 | 0.110 |
Why?
|
Models, Animal | 1 | 2013 | 114 | 0.110 |
Why?
|
Clinical Chemistry Tests | 2 | 2006 | 5 | 0.110 |
Why?
|
Guilt | 1 | 2013 | 5 | 0.110 |
Why?
|
Organizational Culture | 1 | 2013 | 18 | 0.100 |
Why?
|
Surveys and Questionnaires | 3 | 2015 | 1144 | 0.100 |
Why?
|
Quality Improvement | 1 | 2014 | 138 | 0.100 |
Why?
|
Propensity Score | 1 | 2013 | 36 | 0.100 |
Why?
|
Motivation | 1 | 2013 | 85 | 0.100 |
Why?
|
Mammary Glands, Human | 1 | 2012 | 7 | 0.100 |
Why?
|
Morphogenesis | 1 | 2012 | 8 | 0.100 |
Why?
|
Microbiota | 1 | 2013 | 95 | 0.100 |
Why?
|
Quadruplets | 1 | 1992 | 1 | 0.100 |
Why?
|
Body Height | 1 | 1992 | 34 | 0.100 |
Why?
|
Food Contamination | 1 | 2011 | 3 | 0.100 |
Why?
|
Toxoplasma | 1 | 2011 | 7 | 0.100 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 125 | 0.090 |
Why?
|
Reference Values | 1 | 2011 | 186 | 0.090 |
Why?
|
Immunoglobulin A, Secretory | 1 | 2010 | 4 | 0.090 |
Why?
|
Lactoferrin | 1 | 2010 | 9 | 0.090 |
Why?
|
Cultured Milk Products | 1 | 2009 | 3 | 0.080 |
Why?
|
Treatment Outcome | 1 | 2019 | 3485 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 161 | 0.080 |
Why?
|
Models, Nursing | 2 | 2004 | 21 | 0.080 |
Why?
|
Infant Food | 2 | 2004 | 2 | 0.080 |
Why?
|
Personal Satisfaction | 1 | 2008 | 43 | 0.070 |
Why?
|
Equipment Design | 2 | 2007 | 138 | 0.070 |
Why?
|
Observer Variation | 6 | 2000 | 96 | 0.070 |
Why?
|
Midwifery | 1 | 2007 | 1 | 0.070 |
Why?
|
Nursing Diagnosis | 1 | 2007 | 2 | 0.070 |
Why?
|
Kenya | 1 | 2007 | 11 | 0.070 |
Why?
|
Models, Biological | 1 | 2009 | 322 | 0.070 |
Why?
|
Data Collection | 2 | 2002 | 91 | 0.070 |
Why?
|
Toxoplasmosis, Ocular | 1 | 2006 | 2 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2007 | 260 | 0.070 |
Why?
|
Vision Disorders | 1 | 2006 | 20 | 0.070 |
Why?
|
North America | 2 | 2018 | 41 | 0.060 |
Why?
|
Risk Management | 1 | 2005 | 5 | 0.060 |
Why?
|
Ethics, Research | 1 | 2005 | 3 | 0.060 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2005 | 1 | 0.060 |
Why?
|
Toxoplasmosis | 1 | 2005 | 6 | 0.060 |
Why?
|
Nursing Assessment | 1 | 2005 | 20 | 0.060 |
Why?
|
Object Attachment | 1 | 2004 | 1 | 0.060 |
Why?
|
Prenatal Diagnosis | 1 | 2005 | 14 | 0.060 |
Why?
|
Nursing Methodology Research | 1 | 2004 | 31 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2005 | 57 | 0.060 |
Why?
|
Logistic Models | 2 | 2016 | 395 | 0.060 |
Why?
|
Clinical Protocols | 2 | 2014 | 57 | 0.060 |
Why?
|
Health Planning Support | 1 | 2003 | 1 | 0.050 |
Why?
|
Healthy People Programs | 1 | 2003 | 2 | 0.050 |
Why?
|
Databases, Bibliographic | 1 | 2003 | 7 | 0.050 |
Why?
|
Policy Making | 1 | 2003 | 12 | 0.050 |
Why?
|
Politics | 1 | 2003 | 11 | 0.050 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2003 | 25 | 0.050 |
Why?
|
Conflict of Interest | 1 | 2003 | 13 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2003 | 220 | 0.050 |
Why?
|
Holistic Nursing | 1 | 2002 | 4 | 0.050 |
Why?
|
Cross Infection | 1 | 2005 | 301 | 0.050 |
Why?
|
Research Design | 1 | 2002 | 185 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 292 | 0.040 |
Why?
|
Silicones | 1 | 2000 | 11 | 0.040 |
Why?
|
Risk | 1 | 2020 | 204 | 0.040 |
Why?
|
Evaluation Studies as Topic | 3 | 1994 | 32 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2020 | 75 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2006 | 985 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2020 | 112 | 0.040 |
Why?
|
Administration, Oral | 2 | 2010 | 108 | 0.040 |
Why?
|
Single-Blind Method | 2 | 1996 | 102 | 0.040 |
Why?
|
Oceania | 1 | 2018 | 3 | 0.040 |
Why?
|
Asia | 1 | 2018 | 10 | 0.040 |
Why?
|
Africa | 1 | 2018 | 10 | 0.040 |
Why?
|
Europe | 1 | 2018 | 58 | 0.040 |
Why?
|
Internationality | 1 | 2018 | 21 | 0.040 |
Why?
|
North Carolina | 1 | 2018 | 12 | 0.040 |
Why?
|
Databases, Factual | 1 | 2020 | 347 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2020 | 587 | 0.040 |
Why?
|
Food, Fortified | 1 | 2018 | 9 | 0.040 |
Why?
|
F2-Isoprostanes | 1 | 2018 | 7 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2018 | 43 | 0.040 |
Why?
|
Income | 1 | 2018 | 80 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 94 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 189 | 0.030 |
Why?
|
Patient Outcome Assessment | 1 | 2017 | 38 | 0.030 |
Why?
|
Health | 1 | 1996 | 10 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2016 | 43 | 0.030 |
Why?
|
Phylogeny | 1 | 2016 | 51 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 44 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2016 | 58 | 0.030 |
Why?
|
Feces | 1 | 2016 | 103 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2015 | 9 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2015 | 10 | 0.030 |
Why?
|
Biological Availability | 1 | 2015 | 17 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2015 | 181 | 0.030 |
Why?
|
NF-kappa B | 1 | 2015 | 113 | 0.030 |
Why?
|
Cell Line | 1 | 2015 | 273 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 79 | 0.030 |
Why?
|
Transportation of Patients | 1 | 1994 | 3 | 0.030 |
Why?
|
Nurse Clinicians | 1 | 1994 | 9 | 0.030 |
Why?
|
Research Personnel | 1 | 1994 | 19 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 1994 | 24 | 0.030 |
Why?
|
Group Processes | 1 | 1994 | 14 | 0.030 |
Why?
|
Consultants | 1 | 1993 | 1 | 0.030 |
Why?
|
Workload | 1 | 1993 | 29 | 0.030 |
Why?
|
Mammary Glands, Animal | 1 | 2012 | 1 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2012 | 43 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2012 | 8 | 0.020 |
Why?
|
Cesarean Section | 1 | 1992 | 30 | 0.020 |
Why?
|
Fetal Development | 1 | 2012 | 3 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 71 | 0.020 |
Why?
|
Oocysts | 1 | 2011 | 2 | 0.020 |
Why?
|
Antibodies, Protozoan | 1 | 2011 | 5 | 0.020 |
Why?
|
Patient Care Team | 1 | 1993 | 119 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 32 | 0.020 |
Why?
|
Immunoassay | 1 | 2011 | 38 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 29 | 0.020 |
Why?
|
Mice | 1 | 2015 | 1395 | 0.020 |
Why?
|
Bodily Secretions | 1 | 2010 | 1 | 0.020 |
Why?
|
Weights and Measures | 1 | 1990 | 3 | 0.020 |
Why?
|
Methods | 1 | 1990 | 12 | 0.020 |
Why?
|
Cephalometry | 1 | 1989 | 5 | 0.020 |
Why?
|
Trachea | 1 | 2010 | 46 | 0.020 |
Why?
|
Equipment and Supplies | 1 | 1989 | 10 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 474 | 0.020 |
Why?
|
Prognosis | 1 | 2009 | 785 | 0.020 |
Why?
|
Vision, Binocular | 1 | 2006 | 2 | 0.020 |
Why?
|
Vision, Monocular | 1 | 2006 | 2 | 0.020 |
Why?
|
Macula Lutea | 1 | 2006 | 3 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2006 | 11 | 0.020 |
Why?
|
Intelligence Tests | 1 | 2006 | 16 | 0.020 |
Why?
|
Visual Acuity | 1 | 2006 | 41 | 0.020 |
Why?
|
Pattern Recognition, Visual | 1 | 2006 | 18 | 0.020 |
Why?
|
Language Tests | 1 | 2006 | 33 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2005 | 85 | 0.020 |
Why?
|
Sampling Studies | 1 | 2004 | 29 | 0.010 |
Why?
|
Urban Population | 1 | 2004 | 153 | 0.010 |
Why?
|
Electronics | 2 | 1995 | 9 | 0.010 |
Why?
|
Safety | 1 | 2002 | 37 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2000 | 38 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2000 | 406 | 0.010 |
Why?
|
Critical Illness | 1 | 1995 | 117 | 0.010 |
Why?
|
Transducers, Pressure | 1 | 1992 | 4 | 0.010 |
Why?
|